Fintel reports that on December 12, 2025, D. Boral Capital maintained coverage of Anixa Biosciences (NasdaqCM:ANIX) with a Buy recommendation. As of December 6, 2025, the average one-year price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback